A
Alopecia 62
Amorolfine 69
Anemia 55
Anidulafungin 52
Antibiotics, utilization of 34
Archaea 33
Athlete's foot 14
B
Bacteria 33
Balanoposthitis 37
Benzylamines 69
Bifonazole 69
Bone marrow suppression 62
Burning 34
Butenafine 69
Butoconazole 36
C
Candidal balanitis 38
Candidal intertrigo, systemic agents for 84
Candidemia 58
Candidiasis, topical agents for 73
Cardiac dysfunction 82
Castellani's paint 70
Cell membrane 53
Cell wall 53
Central nervous system 58
Cerebrospinal fluid 57
Chemical structure 52
Circinate balanitis 38
Clioquinol 53
Cryptococcus neoformans 63
D
Dermoscopy 20
Distal lateral subungual onychomycosis 19
E
Eberconazole 69
Efinaconazole 69
Electrolyte abnormalities 55
Epidermophyton floccosum 19
Erythematous papules, margin of 48f
Estrogen 35
H
Hailey–Hailey disease 12
Hair 8
Hamycin 54
Headache 55
Heart failure, congestive 75
Hepatic dysfunction 82
Hepatotoxicity 62
Human immunodeficiency virus 45
Hydroxypyridinones 70
Hyperkeratotic lesions 71
Hypersensitivity 57
Hypopigmentation 25f
I
Immunity, cell-mediated 44
Incognito 45
Indian Association of Dermatologists, Venereologists and Leprologists Task Force against Recalcitrant Tinea 67
Indian Expert Forum Consensus Group 67
Interdigital tinea pedis 15f
Iodoquinol 53
Isoconazole 72
Itching 34
M
Majocchi's granuloma 11
Meatitis 40
Micaceous balanitis 38
Micafungin 52
Morpholines 69
Multiple site involvement 3
O
Obesity 39
Oral contraceptives 35
Oral immunosuppressants 45
Oral itraconazole 81
Oxaboroles 70
Oxiconazole 69
S
Scaly lesions 71
Sertaconazole 69
Sodium-glucose cotransporter-2 inhibitors, utilization of 35
Soreness 34
Subacute cutaneous lupus erythematosus 75
SUBA-itraconazole 58
T
Tavaborole 70
Terconazole 36
drug of choice for 80
inflammatory 17f
clinical presentations of 7
et cruris 3
rounded erythematous scaly lesion of 9f
et corporis 10
intensely itchy patch of 13f
healing 29f
treatment of 76
chronic 3
diagnosis of 20
recurrent 3
progenetica 50f
pubogenetica 47
types of 8t
drug of choice for 79
Tioconazole 36
Tolnaftate 70
Trachyonychia 19